Poziotinib
id:
poziotinib-285-11630235
title:
Poziotinib
text:
Poziotinib is a drug in development by Hanmi Pharmaceutical, Luye Pharma (China), and Spectrum Pharmaceuticals for various cancers. It is built on an anilino-quinazoline scaffold and inhibits the epidermal growth factor receptors EGFR, HER2/neu, and Her 4 and binds covalently to its targets. It was discovered at Hanmi; in August 2014 Hanmi exclusively licensed rights in China to the Chinese company Luye Pharma and in February 2015 Hanmi licensed rights in the rest of the world outside of South K
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Poziotinib
date created:
date modified:
2023-11-11T21:06:06Z
main entity:
{"identifier":"Q27088426","url":"https://www.wikidata.org/entity/Q27088426"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/e/ee/Poziotinib.png","width":827,"height":640}
fields total:
13
integrity:
15